dismiss

The 1st Ever Medical World Americas is in Houston, TX, April 28-30 - Get a Free 1-Day Pass!

SEARCH

Current Location: DOTmed News > Industry Headlines > This Story

(1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

 

More Industry Headlines

Doc fix bill puts clinical decision support in the spotlight Appropriateness criteria is the new reality.

False positive results: not as bad as you thought But women will still undergo additional breast cancer tests.

ECRI's top 10 patient safety concerns HIT, care coordination, drug shortages top safety list.

FDA clears new CT system from Siemens Ideal for challenging cases.

FDA OKs Shimadzu's new R/F system For a wide variety of exams.

Gov. Jan Brewer signs breast density law Arizona becomes the latest state with inform legislation.

CT can detect arterial plaque for diabetics CCTA is a welcome development.

Goggles that illuminate cancer cells Could they reduce second surgeries?

Philips suspends CT and PET/CT production at Ohio facility Setback for customers and the company.

Varian's seven year patent dispute comes to an end Company will pay about $35 million.

Blood test may beat
imaging in cancer prediction

Blood test could detect lung cancer up to five years before CT scans

by Brendon Nafziger , DOTmed News Associate Editor
A blood test could detect about half of lung cancers up to five years before other tests, according to a team of British scientists.

In a series of papers to be presented Sunday at the annual meeting of the American Society of Clinical Oncology in Chicago, the scientists from the company Oncimmune tout their "Early CDT-Lung Test" for finding around 40 percent of lung cancers years before they show up on CT scans.

Story Continues Below Advertisement

Introducing the Radimetrics Enterprise Platform

Merge & mobilize patient dose histories and current exam details across the organization. Because Each Dose Matters.Visit us at SIIM, Booth #217



The company hopes the test, commercially available in the United States starting Tuesday, will not only save lives by detecting cancer early, but drive down health care costs.

The test works by looking for antibodies, called auto-antibodies, which the body produces to combat cancer.

As Geoffrey Hamilton-Fairley, executive chairman of Oncimmune, explained to DOTmed News, cancer cells divide rapidly. During division, they release antigens that the body recognizes as foreign, which it combats with auto-antibodies.

"Everybody has a background count of these auto-antibodies," Hamilton-Fairley said, which actually increase as we age, possibly because our bodies are fighting off many less aggressive cancers successfully.

The research originated with John Robertson, a professor at the University of Nottingham. As part of their yearly check-up, his patients at high-risk for breast cancer had their blood drawn. If they came down with cancer, Robertson went back to their blood samples and retroactively tested them for the auto-antibodies, finding that over half of the cancers could have been found four years before diagnosis.

For the current test, patients have their blood samples mailed to Oncimmune's U.S. testing facility in De Soto, Kan., just outside Kansas City.

The researchers then choose a selection of around six antigens that they pass a patient's blood sample over. If auto-antibodies are present, they'll bind to the antigens. After doing this a few times for accuracy, researchers develop the patient's antigen "fingerprint." This fingerprint is then compared against a population cut-off to judge the patient's risk for developing cancer.

Eventually, physicians will compare a patient's fingerprint against those taken from previous years, and not just population cut-offs, for more accurate readings, Hamilton-Fairley said.

"We'll end up with your own individual antigen fingerprint," he said, "and you'll be able to compare that year by year, and over time you'll pay more attention if you stray from the personal profile."

For now, they recommend one test about every five years, but as the patient ages or if there are risk factors - specifically, smoking - doctors might look at it more often.

Continue reading Blood test could detect lung cancer up to five years before CT scans ...
  Pages: 1 - 2 - 3 >>

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED